Post by Medicines for Malaria Venture

Global health is being asked to do more with less. At the same time, the possibilities for #innovation have never been greater.   That is why MMV and Drugs for Neglected Diseases initiative (DNDi) are pooling regulatory expertise within a new Joint Regulatory Platform, led by Fabienne Benoist. Developing and delivering medicines for some of the world’s most underserved diseases requires novel approaches. Bringing these innovations to patients faster also requires earlier collaboration with regulatory authorities, more adaptive approaches to evidence, and in some cases, the development of entirely new standards. This joint platform is designed to help meet that need. By bringing together the regulatory expertise of both organizations, we will: → Pool our knowledge and speak with one voice  → Help define the evidence standards that future medicines will require  → Strengthen our impact  We believe this is a model the wider global health community can build on—because ultimately, success is measured by one thing: getting better medicines to patients faster. Read more: bit.ly/4a4OEEP